EU reaches deal with Moderna on COVID-19 vaccine supply - source

The European Union has reached a deal with U.S. biotech firm Moderna for the supply of its COVID-19 vaccine candidate, an EU official told Reuters on Tuesday.

Last week Moderna said its experimental vaccine was 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial. In August the EU's executive Commission, which co-leads talks with vaccine makers on behalf of member states, said preliminary talks with Moderna had been concluded with the aim of signing a contract for the supply of 80 million doses of its vaccine, with the option of buying another 80 million.

The deal is expected to be formally sealed in the coming days.

Also Read: EU welcomes Moderna vaccine result, says more supply deals to come

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)